213 related articles for article (PubMed ID: 16964373)
1. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel stimulates chromosomal fusion and instability in cells with dysfunctional telomeres: implication in multinucleation and chemosensitization.
Park JE; Woo SR; Kang CM; Juhn KM; Ju YJ; Shin HJ; Joo HY; Park ER; Park IC; Hong SH; Hwang SG; Lee JK; Kim HK; Cho MH; Park GH; Lee KH
Biochem Biophys Res Commun; 2011 Jan; 404(2):615-21. PubMed ID: 21144828
[TBL] [Abstract][Full Text] [Related]
3. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
4. Clonal cell populations unresponsive to radiosensitization induced by telomerase inhibition.
Ju YJ; Shin HJ; Park JE; Juhn KM; Woo SR; Kim HY; Han YH; Hwang SG; Hong SH; Kang CM; Yoo YD; Park WB; Cho MH; Park GH; Lee KH
Biochem Biophys Res Commun; 2010 Nov; 402(2):198-202. PubMed ID: 20875790
[TBL] [Abstract][Full Text] [Related]
5. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas.
Scheel C; Schaefer KL; Jauch A; Keller M; Wai D; Brinkschmidt C; van Valen F; Boecker W; Dockhorn-Dworniczak B; Poremba C
Oncogene; 2001 Jun; 20(29):3835-44. PubMed ID: 11439347
[TBL] [Abstract][Full Text] [Related]
6. Telomere dysfunction: multiple paths to the same end.
Harrington L; Robinson MO
Oncogene; 2002 Jan; 21(4):592-7. PubMed ID: 11850784
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.
Zimmermann S; Biniossek ML; Maurer C; Münzer P; Pantic M; Veelken H; Martens UM
Proteomics; 2009 Nov; 9(22):5175-87. PubMed ID: 19834903
[TBL] [Abstract][Full Text] [Related]
8. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.
Rudolph KL; Millard M; Bosenberg MW; DePinho RA
Nat Genet; 2001 Jun; 28(2):155-9. PubMed ID: 11381263
[TBL] [Abstract][Full Text] [Related]
9. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
Vaziri H; Benchimol S
Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Li H; Cao Y; Berndt MC; Funder JW; Liu JP
Oncogene; 1999 Nov; 18(48):6785-94. PubMed ID: 10597287
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
12. Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.
Preto A; Singhrao SK; Haughton MF; Kipling D; Wynford-Thomas D; Jones CJ
Oncogene; 2004 May; 23(23):4136-45. PubMed ID: 15064743
[TBL] [Abstract][Full Text] [Related]
13. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.
Plug-DeMaggio AW; Sundsvold T; Wurscher MA; Koop JI; Klingelhutz AJ; McDougall JK
Oncogene; 2004 Apr; 23(20):3561-71. PubMed ID: 15077181
[TBL] [Abstract][Full Text] [Related]
14. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition and telomere targeting in hematopoietic cancer cell lines with small non-nucleosidic synthetic compounds (BIBR1532).
El Daly H; Martens UM
Methods Mol Biol; 2007; 405():47-60. PubMed ID: 18369817
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of telomeric instability.
Baird DM
Cytogenet Genome Res; 2008; 122(3-4):308-14. PubMed ID: 19188700
[TBL] [Abstract][Full Text] [Related]
17. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse.
Maser RS; Wong KK; Sahin E; Xia H; Naylor M; Hedberg HM; Artandi SE; DePinho RA
Mol Cell Biol; 2007 Mar; 27(6):2253-65. PubMed ID: 17145779
[TBL] [Abstract][Full Text] [Related]
18. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
19. Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells.
Ferrón S; Mira H; Franco S; Cano-Jaimez M; Bellmunt E; Ramírez C; Fariñas I; Blasco MA
Development; 2004 Aug; 131(16):4059-70. PubMed ID: 15269166
[TBL] [Abstract][Full Text] [Related]
20. Long but dysfunctional telomeres correlate with chromosomal radiosensitivity in a mouse AML cell line.
Finnon P; Wong HP; Silver AR; Slijepcevic P; Bouffler SD
Int J Radiat Biol; 2001 Dec; 77(12):1151-62. PubMed ID: 11747540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
